Key result
Improved intraoperative hypotension control in non-cardiac surgery is linked to savings of ~$272 per patient.
Why the study?
Intraoperative hypotension in non-cardiac surgery is linked to myocardial injury, acute kidney injury, and mortality, but its association with US hospital expenditures needed quantification.
Does improved intraoperative hypotension control reduce hospital costs associated with AKI and MINS in non-cardiac surgical patients?
Population
Simulated non-cardiac surgical patients in the US (10,000 trial per simulation)
Comparison
Intraoperative hypotension vs hypotension control
Design
Monte Carlo simulation model
Authors
Loading...
Supports potential cost savings from hypotension control in non-cardiac surgery; leaves open causal confirmation via randomized trials.
Does improved intraoperative hypotension control reduce hospital costs associated with AKI and MINS in non-cardiac surgical patients?
Effect estimate: Cost reduction of $272 per patient (unadjusted AKI model) (95% CI $223-$321)
Improved intraoperative hypotension control in non-cardiac surgery may yield significant hospital cost savings by reducing the incidence of AKI and myocardial injury.
Keuffel et al. (2019) studied Intraoperative hypotension in non-cardiac surgery. Intraoperative hypotension control vs. Intraoperative hypotension was evaluated on Hospital expenditures associated with intraoperative hypotension (Cost reduction of $272 per patient (unadjusted AKI model), 95% CI $223-$321). Improved intraoperative hypotension control in non-cardiac surgery is associated with mean hospital cost reductions ranging from $1.2 to $4.6 million per year per 10,000 patients.